Advertisement
News
Advertisement

June 27-29, 2012, Hyatt Regency Boston

Tue, 05/22/2012 - 5:45am
The Associated Press

Elsevier Business Intelligence(http://www.elsevierbi.com/), the

medtech industry's leading provider of strategic partnership and

investment conferences, announced today that 30-year device industry

veteran Don Urbanowicz, Principal, Urbanowicz Consulting, LLC, will

host an early-stage start-up investment strategy session at the

'Investment in Innovation (IN3) Medical Device 360 Boston' investor

conference, June 27-29, 2012, at the Hyatt Regency Boston.

Urbanowicz, former senior-level executive with Stryker Orthopaedics,

Sofamor Danek, Aircast and Smith & Nephew, will host a one-hour

session on Thursday evening, June 28th, titled "Top 10 Value-Drivers

Strategics Look for in Pre-Revenue Startups," which will examine in

detail what medical device acquirers or licensors are specifically

looking for in pre-revenue companies, and describe how startups can

best position their company and technology with each prospective

buyer.

IN3 Medical Device 360 Boston will also feature presentations by more

than 25 development- to commercial-stage startups that are seeking

funding and/or strategic partnership, developing products covering the

spectrum of diagnostic and therapeutic device markets. Presenters

confirmed to date include Aerolase, CoolSpine, Genomind, Harbor

MedTech, MGI Medical, Neuronetrix, Poiesis Medical, Soft Tissue

Regeneration, StnDrd Infusion, Stroma Medical, Suspension Orthopaedic

Solutions, Thermimage, ThermopeutiX, Titan Spine, and Vertiflex.

The event also will feature an outstanding agenda of panels,

presentations and networking sessions with industry thought leaders

discussing the most pressing issues facing the global device industry

in 2012 and beyond. Confirmed participating speakers include

senior-level strategic decision makers from Ascent Biomedical

Ventures, Boston Scientific, Covidien, Cowen Healthcare Royalty

Partners, DePuy Mitek and Codman/Johnson & Johnson, Fidelity

Biosciences, NGN Capital, NMT Capital, Novartis Venture Funds, Polaris

Venture Partners, Siemens Venture Capital, Smith & Nephew Endoscopy,

SV Life Sciences Advisers, Wright Medical Technology, and many more.

Interactive panel topics will include: Intellectual Property's Role in

Start-Up Valuations, What Big Companies Want to See in a Start-Up

Before Buying; Complying with the New Physician Sunshine Law; and,

Medtech Investing: Hear What It Takes to Get a VC to Say Yes. In

addition, Robert Pearson, president of W20 Group, will give a special

Social Media Keynote Presentation, and a networking cocktail reception

will be held the evening of June 28th. Partnering software will be

available to all registered attendees prior to the conference so that

one-on-one onsite meetings can be pre-arranged.

Emerging medtech companies that would like to apply to present in

Boston should contact Kayleen Kell at 949-797-7142, or email

k.kell@elsevier.com(mailto:k.kell@elsevier.com).

The event will be held at the Hyatt Regency Boston, centrally located

in downtown Boston. Co-sponsors include Ronald Trahan Associates Inc.,

AptivSolutions, Current Partnering, Medmarc with The Hartford and

Biomedic-Insure, UBM TechInsights, FreeMind, Scisive, Mass Medical

Angels, Life Science Intelligence, and marketwire. Visit

www.IN3Boston.com(http://www.in3boston.com/) for full conference and

registration details. EBI will be hosting one additional IN3 Medical

Device 360 event in 2012, its Summit-San Francisco, October 15-17;

visit

http://www.elsevierbi.com/conferences(http://www.elsevierbi.com/conferences)

for more information.

About Elsevier Business IntelligenceElsevier Business Intelligence

(EBI), an Elsevier company built on the heritage of F-D-C Reports,

Windhover Information and Medtech Insight, is a global information

supplier providing business intelligence on regulatory, business and

reimbursement issues that are vital to the healthcare industry.

Through a range of products including publications, conferences,

databases(http://www.istockanalyst.com/business/news/5040593/elsevier-business-intelligence-to-host-in3-east-at-hyatt-regency-boston-on-june-21-23-2011)

and reports, EBI places biopharma and medical device professionals,

and those who focus on these industries, at the forefront of

knowledge, by providing the perfect combination of news and

information together with penetrating insight and analysis. EBI

(www.elsevierbi.com(http://www.elsevierbi.com/)) has offices in the

U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine,

Calif.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading